Prognosis of Apical Hypertrophic Cardiomyopathy in Patients With Implantable Cardioverter Defibrillators

被引:0
|
作者
Kondo, Yusuke
Nakano, Miyo
Nakano, Masahiro
Kajiyama, Takatsugu
Kobayashi, Yoshio
机构
关键词
Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator (ICD);
D O I
10.1161/circ.148.suppl_1.19218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A19218
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
    Maron, Barry J.
    Spirito, Paolo
    Shen, Win-Kuang
    Haas, Tammy S.
    Formisano, Francesco
    Link, Mark S.
    Epstein, Andrew E.
    Almquist, Adrian K.
    Daubert, James P.
    Lawrenz, Thorsten
    Boriani, Giuseppe
    Estes, N. A. Mark, III
    Favale, Stefano
    Piccininno, Marco
    Winters, Stephen L.
    Santini, Massimo
    Betocchi, Sandro
    Arribas, Fernando
    Sherrid, Mark V.
    Buja, Gianfranco
    Semsarian, Christopher
    Bruzzi, Paolo
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (04): : 405 - 412
  • [22] Long-term follow-up of hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillators
    Gonzalez-Enriquez, Susana
    Rodriguez-Entem, Felipe
    Olalla, Juan J.
    Casanova, Miguel A.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (05): : 552 - 553
  • [23] LONG-TERM OUTCOME OF NONCOMPACTION CARDIOMYOPATHY PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS COMPARED WITH PATIENTS WITH DILATED OR HYPERTROPHIC CARDIOMYOPATHY
    Caliskan, Kadir
    Yap, Sing-Chien
    Schinkel, Arend
    Constantinescu, Alina
    Michels, Michelle
    Manintveld, Olivier
    Szili-Torok, Tamas
    Theuns, Dominic
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 356 - 356
  • [24] Long-Term Clinical Outcomes in Young Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators
    Burrows, Austin
    Madias, Christopher
    Rowin, Ethan J.
    Maron, Martin S.
    Maron, Barry J.
    CIRCULATION, 2019, 140
  • [25] Inducibility in electrophysiologic study does not predict appropriate interventions of implantable cardioverter/defibrillators in patients with hypertrophic cardiomyopathy
    Buschler, H.
    Faber, L.
    Vogt, J.
    Heintze, J.
    Hoppe, C.
    Lamp, B.
    Horstkotte, D.
    EUROPEAN HEART JOURNAL, 2005, 26 : 385 - 385
  • [26] Reduction of Inappropriate Shocks Over Time in Hypertrophic Cardiomyopathy Patients With Subcutaneous Implantable Cardioverter-Defibrillators
    Narayanan, Chockalingam
    Gionfriddo, William
    Shrestha, Srijan
    Koethe, Benjamin
    Katcher, Benjamin
    Garlitski, Ann
    Weinstock, Jonathan
    Homoud, Munther
    Maron, Barry
    Maron, Martin S.
    Rowin, Ethan J.
    Madias, Christopher
    CIRCULATION, 2021, 144
  • [27] IMPLANTATION OF NONTHOREACOTOMY CARDIOVERTER-DEFIBRILLATORS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    PHILIPPON, F
    EPSTEIN, AE
    VOSHAGE, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A112 - A112
  • [29] Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable cardioverter-defibrillators
    Janse, MJ
    De Bakker, JMT
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0L) : L15 - L20
  • [30] Role of implantable cardioverter defibrillators in dilated cardiomyopathy
    Cappato, R
    Negroni, S
    Bentivegna, S
    Bianchetti, F
    Pecora, D
    Morandi, F
    Furlanello, F
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (01) : S106 - S109